114 related articles for article (PubMed ID: 33792239)
21. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
Mahmud A; Feely J
Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
[TBL] [Abstract][Full Text] [Related]
22. Nonfunctioning adrenal incidentaloma affecting central blood pressure and arterial stiffness parameters.
Akkan T; Altay M; Ünsal Y; Dağdeviren M; Beyan E
Endocrine; 2017 Dec; 58(3):513-520. PubMed ID: 29043559
[TBL] [Abstract][Full Text] [Related]
23. Central hemodynamics and arterial stiffness in Gujarati diabetics not receiving any antihypertensive: A case-control study based on oscillometric pulse wave analysis.
Solanki JD; Munshi HB; Mehta HB; Shah CJ
J Family Med Prim Care; 2019 Apr; 8(4):1352-1358. PubMed ID: 31143720
[TBL] [Abstract][Full Text] [Related]
24. QT interval in patients with primary aldosteronism and low-renin essential hypertension.
Maule S; Mulatero P; Milan A; Leotta G; Caserta M; Bertello C; Rabbia F; Veglio F
J Hypertens; 2006 Dec; 24(12):2459-64. PubMed ID: 17082730
[TBL] [Abstract][Full Text] [Related]
25. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.
Catena C; Colussi GL; Marzano L; Sechi LA
Horm Metab Res; 2012 Mar; 44(3):188-93. PubMed ID: 22351477
[TBL] [Abstract][Full Text] [Related]
26. A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study.
Ullrich NJ; Prabhu SP; Reddy AT; Fisher MJ; Packer R; Goldman S; Robison NJ; Gutmann DH; Viskochil DH; Allen JC; Korf B; Cantor A; Cutter G; Thomas C; Perentesis JP; Mizuno T; Vinks AA; Manley PE; Chi SN; Kieran MW
Neuro Oncol; 2020 Oct; 22(10):1527-1535. PubMed ID: 32236425
[TBL] [Abstract][Full Text] [Related]
27. Comparison of pulse wave analysis parameters by oscillometry in hypertensive diabetic and nondiabetic patients in a Brazilian outpatient care.
Resende LAPR; Silva MAV; Resende JAM; Resende EAMR; Silva VJD; Correia D
Medicine (Baltimore); 2019 Dec; 98(50):e18100. PubMed ID: 31852069
[TBL] [Abstract][Full Text] [Related]
28. Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D.
Carrara D; Bruno RM; Bacca A; Taddei S; Duranti E; Ghiadoni L; Bernini G
J Hypertens; 2016 Nov; 34(11):2199-205. PubMed ID: 27648718
[TBL] [Abstract][Full Text] [Related]
29. A non-invasive left ventricular pressure-strain loop study on myocardial work in primary aldosteronism.
Chen YL; Xu TY; Xu JZ; Zhu LM; Li Y; Wang JG
Hypertens Res; 2021 Nov; 44(11):1462-1470. PubMed ID: 34417559
[TBL] [Abstract][Full Text] [Related]
30. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
[TBL] [Abstract][Full Text] [Related]
31. Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism.
Haze T; Hirawa N; Yano Y; Tamura K; Kurihara I; Kobayashi H; Tsuiki M; Ichijo T; Wada N; Katabami T; Yamamoto K; Oki K; Inagaki N; Okamura S; Kai T; Izawa S; Yamada M; Chiba Y; Tanabe A; Naruse M
Atherosclerosis; 2021 May; 324():84-90. PubMed ID: 33831673
[TBL] [Abstract][Full Text] [Related]
32. Assessing maternal cardiac function by obstetricians: technique and reference ranges.
DeVore GR; Polanco B
Am J Obstet Gynecol; 2023 Aug; 229(2):155.e1-155.e18. PubMed ID: 36627073
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of non-invasive measurement of central blood pressure and arterial stiffness in shock.
Markakis K; Pagonas N; Georgianou E; Zgoura P; Rohn BJ; Bertram S; Seidel M; Bettag S; Trappe HJ; Babel N; Westhoff TH; Seibert FS
Eur J Clin Invest; 2021 Sep; 51(9):e13587. PubMed ID: 34022074
[TBL] [Abstract][Full Text] [Related]
34. Anatomical and functional remodeling of left ventricle in patients with primary aldosteronism and concomitant albuminuria.
Kao TW; Wu XM; Liao CW; Tsai CH; Chen ZW; Chang YY; Lee BC; Chiu YW; Lai TS; Wu VC; Lin YH; Hung CS;
Ther Adv Chronic Dis; 2023; 14():20406223221143253. PubMed ID: 36860935
[TBL] [Abstract][Full Text] [Related]
35. Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism.
Yamashita K; Morimoto S; Seki Y; Watanabe D; Ichihara A
Hypertens Res; 2019 Dec; 42(12):1951-1960. PubMed ID: 31409916
[TBL] [Abstract][Full Text] [Related]
36. Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials.
Mannick JB; Teo G; Bernardo P; Quinn D; Russell K; Klickstein L; Marshall W; Shergill S
Lancet Healthy Longev; 2021 May; 2(5):e250-e262. PubMed ID: 33977284
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
38. Continuum of Renin-Independent Aldosteronism in Normotension.
Baudrand R; Guarda FJ; Fardella C; Hundemer G; Brown J; Williams G; Vaidya A
Hypertension; 2017 May; 69(5):950-956. PubMed ID: 28289182
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Echocardiographic Changes Between Surgery and Medication Treatment in Patients With Primary Aldosteronism.
Ueda T; Tsurutani Y; Osada J; Inoue K; Hoshino Y; Ono M; Nakai K; Saito J; Yumoto K; Nishikawa T
J Am Heart Assoc; 2022 Jul; 11(13):e023813. PubMed ID: 35766291
[TBL] [Abstract][Full Text] [Related]
40. Oscillometric estimation of central blood pressure: validation of the Mobil-O-Graph in comparison with the SphygmoCor device.
Weiss W; Gohlisch C; Harsch-Gladisch C; Tölle M; Zidek W; van der Giet M
Blood Press Monit; 2012 Jun; 17(3):128-31. PubMed ID: 22561735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
